TORONTO DOMINION BANK - ZOMEDICA PHARMACEUTICALS COR ownership

ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 33 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TORONTO DOMINION BANK ownership history of ZOMEDICA PHARMACEUTICALS COR
ValueSharesWeighting
Q3 2020$0200.0%0.00%
Q2 2020$0200.0%0.00%
Q1 2020$0200.0%0.00%
Q4 2019$020
-92.2%
0.00%
Q3 2019$0255
-39.6%
0.00%
Q2 2019$0422
+421.0%
0.00%
Q1 2019$0810.0%0.00%
Q4 2018$0810.0%0.00%
Q3 2018$081
+118.9%
0.00%
Q2 2018$037
+85.0%
0.00%
Q1 2018$0200.0%0.00%
Q4 2017$0200.00%
Other shareholders
ZOMEDICA PHARMACEUTICALS COR shareholders Q3 2020
NameSharesValueWeighting ↓
Cambridge Investment Research Advisors, Inc. 12,073,080$4,226,0000.04%
jvl associates llc 58,500$20,0000.02%
Ameritas Investment Partners, Inc. 2,890$1,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 64,578$23,0000.00%
UBS Group AG 7,600$3,0000.00%
RHUMBLINE ADVISERS 45,375$16,0000.00%
BNP PARIBAS FINANCIAL MARKETS 9,767$3,418,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 28,131$10,0000.00%
BANK OF AMERICA CORP /DE/ 451$00.00%
WELLS FARGO & COMPANY/MN 76,531$26,0000.00%
View complete list of ZOMEDICA PHARMACEUTICALS COR shareholders